(Q22306202)

2

Peizhan

Chen

1 reference

10 April 2023

Jingquan Li

3

Jingquan

Li

1 reference

10 April 2023

Ruiai Chu

4

Ruiai

Chu

1 reference

10 April 2023

Dong Xie

5

Dong

Xie

1 reference

10 April 2023

Hui Wang

6

Hui

The Journal of Clinical Endocrinology and Metabolism

Wang

1 reference

10 April 2023

language of work or name

English

0 references

publication date

July 2014

0 references

published in

0 references

volume

99

0 references

issue

7

0 references

page(s)

2327-2336

0 references

cites work

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

The effect of various vitamin D supplementation regimens in breast cancer patients

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

A global representation of vitamin D status in healthy populations

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case–control study

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Meta-analysis: Circulating vitamin D and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

A systematic review of vitamin D status in populations worldwide

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Association between serum 25(OH)D and death from prostate cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D and cancer: a review of molecular mechanisms

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

https://api.crossref.org/works/10.1210%2FJC.2013-4320

1 reference

7 January 2021

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D deficiency: a worldwide problem with health consequences.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D deficiency: a global perspective

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Clinical outcomes of vitamin D deficiency and supplementation in cancer patients.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Serum vitamin D and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021

Sunlight and Vitamin D: A global perspective for health

1 reference

https://api.crossref.org/works/10.1210%2FJC.2013-4320

7 January 2021